Quantifying and Characterizing the Presence of Insulin Overbasalization in a Family Medicine Practice

The American Diabetes Association advises clinicians of the potential for insulin overbasalization in the management of type 2 diabetes. Described as the titration of basal insulin beyond an appropriate dose, overbasalization increases risks for adverse effects such as hypoglycemia and weight gain w...

Full description

Saved in:
Bibliographic Details
Published inClinical diabetes Vol. 42; no. 2; pp. 266 - 273
Main Authors Stewart-Lynch, Autumn, Meyers, Rebekah, Sidig, Dina, McConville, Sea-Oh, Heiple, Lindsay
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The American Diabetes Association advises clinicians of the potential for insulin overbasalization in the management of type 2 diabetes. Described as the titration of basal insulin beyond an appropriate dose, overbasalization increases risks for adverse effects such as hypoglycemia and weight gain without achieving the glycemic targets needed to optimally manage the disease. There is a need to determine the prevalence of and clinical factors that can lead to overbasalization. This study aimed to assess the prevalence of and characterize the patient variables associated with overbasalization in a family medicine practice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0891-8929
1945-4953
DOI:10.2337/cd23-0044